赛生药业（06600）发布公告，于2024年4月26日，公司首次公开发售后购股权计划项下授出的28.64万份购股权已根据首次公开发售后购股权计划的规则获行使。
责任编辑：卢昱君
赛生药业：授出的28.64万份购股权已获行使
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.